Cargando…
SUMOtherapeutics for Ischemic Stroke
The small, ubiquitin-like modifier (SUMO) is a post-translational modifier with a profound influence on several key biological processes, including the mammalian stress response. Of particular interest are its neuroprotective effects, first recognized in the 13-lined ground squirrel (Ictidomys tride...
Autores principales: | Karandikar, Paramesh, Gerstl, Jakob V. E., Kappel, Ari D., Won, Sae-Yeon, Dubinski, Daniel, Garcia-Segura, Monica Emili, Gessler, Florian A., See, Alfred Pokmeng, Peruzzotti-Jametti, Luca, Bernstock, Joshua D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221934/ https://www.ncbi.nlm.nih.gov/pubmed/37242456 http://dx.doi.org/10.3390/ph16050673 |
Ejemplares similares
-
Neural precursor cells in the ischemic brain – integration, cellular crosstalk, and consequences for stroke recovery
por: Hermann, Dirk M., et al.
Publicado: (2014) -
Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma
por: Karandikar, Paramesh V., et al.
Publicado: (2023) -
Intracranial pressure monitoring in posterior fossa lesions—systematic review and meta-analysis
por: Won, Sae-Yeon, et al.
Publicado: (2022) -
Blood Clots May Compromise Intracranial Pressure Measurement Using Air-Pouch Intracranial Pressure Probes
por: Won, Sae-Yeon, et al.
Publicado: (2023) -
Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming
por: Bernstock, Joshua D., et al.
Publicado: (2017)